Key points are not available for this paper at this time.
These factors can be helpful to predict patients' outcome and tumor response to ICI. They should be implemented prospectively in ICI based clinical trials to develop reliable algorithms for palliative NSCLC treatment.
Brueckl et al. (2020) studied this question.